ANXA2 and breast carcinoma: Recent studies also demonstrated that female breast cancer patients have a higher expression level of serum exosomal-annexin A2 (Exo-AnxA2) than healthy subjects, especially for TNBC, rather than luminal and HER2-positive breast cancer (Chaudhary et al., 2020).